{"assetProfile": {"address1": "1201 Orange Street", "address2": "Suite 600", "city": "Wilmington", "state": "DE", "zip": "19801", "country": "United States", "phone": "484 254 6134", "website": "https://www.nrxpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-free formulation of ketamine for intravenous infusion and for the treatment of suicidal depression. The company has a license agreement with Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd.; Apkarian Technologies; development and license agreement with Glytech, LLC; and Sarah Herzog Memorial Hospital. NRx Pharmaceuticals, Inc. was founded in 2015 and is based in Wilmington, Delaware.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Jonathan C. Javitt M.D., M.P.H.", "age": 67, "title": "Co-Founder, Chief Scientist Officer, Chairman & Interim CEO", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": {"raw": 825000, "fmt": "825k", "longFmt": "825,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Matthew Patrick Duffy", "age": 61, "title": "Chief Business Officer & Co-CEO of Hope Therapeutics", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": {"raw": 338000, "fmt": "338k", "longFmt": "338,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Michael S. Abrams", "age": 54, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Riccardo  Panicucci Ph.D.", "age": 63, "title": "Chief Manufacturing & Technology Officer", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": {"raw": 240000, "fmt": "240k", "longFmt": "240,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Suzanne  Messere", "title": "Investor Relations", "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Philip T. Lavin Ph.D.", "age": 77, "title": "Chief Methodologist", "yearBorn": 1947, "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400}, "calendarEvents": {"maxAge": 1, "earnings": {"earningsDate": [], "earningsCallDate": [], "earningsAverage": {}, "earningsLow": {}, "earningsHigh": {}, "revenueAverage": {"raw": 6825000, "fmt": "6.83M", "longFmt": "6,825,000"}, "revenueLow": {"raw": 500000, "fmt": "500k", "longFmt": "500,000"}, "revenueHigh": {"raw": 13500000, "fmt": "13.5M", "longFmt": "13,500,000"}}, "exDividendDate": {}, "dividendDate": {}}, "earningsTrend": {"trend": [{"maxAge": 1, "period": "0q", "endDate": "2025-09-30", "growth": {}, "earningsEstimate": {"avg": {}, "low": {}, "high": {}, "yearAgoEps": {}, "numberOfAnalysts": {}, "growth": {}, "earningsCurrency": null}, "revenueEstimate": {"avg": {"raw": 6825000, "fmt": "6.83M", "longFmt": "6,825,000"}, "low": {"raw": 500000, "fmt": "500k", "longFmt": "500,000"}, "high": {"raw": 13500000, "fmt": "13.5M", "longFmt": "13,500,000"}, "numberOfAnalysts": {"raw": 4, "fmt": "4", "longFmt": "4"}, "yearAgoRevenue": {"raw": 0, "fmt": null, "longFmt": "0"}, "growth": {"raw": 0.0, "fmt": "0.00%"}, "revenueCurrency": "USD"}, "epsTrend": {"current": {}, "7daysAgo": {}, "30daysAgo": {}, "60daysAgo": {}, "90daysAgo": {}, "epsTrendCurrency": null}, "epsRevisions": {"upLast7days": {}, "upLast30days": {}, "downLast30days": {}, "downLast7Days": {}, "downLast90days": {}, "epsRevisionsCurrency": null}}, {"maxAge": 1, "period": "+1q", "endDate": "2025-12-31", "growth": {}, "earningsEstimate": {"avg": {}, "low": {}, "high": {}, "yearAgoEps": {}, "numberOfAnalysts": {}, "growth": {}, "earningsCurrency": null}, "revenueEstimate": {"avg": {"raw": 15000000, "fmt": "15M", "longFmt": "15,000,000"}, "low": {"raw": 1000000, "fmt": "1M", "longFmt": "1,000,000"}, "high": {"raw": 29000000, "fmt": "29M", "longFmt": "29,000,000"}, "numberOfAnalysts": {"raw": 4, "fmt": "4", "longFmt": "4"}, "yearAgoRevenue": {"raw": 0, "fmt": null, "longFmt": "0"}, "growth": {"raw": 0.0, "fmt": "0.00%"}, "revenueCurrency": "USD"}, "epsTrend": {"current": {}, "7daysAgo": {}, "30daysAgo": {}, "60daysAgo": {}, "90daysAgo": {}, "epsTrendCurrency": null}, "epsRevisions": {"upLast7days": {}, "upLast30days": {}, "downLast30days": {}, "downLast7Days": {}, "downLast90days": {}, "epsRevisionsCurrency": null}}, {"maxAge": 1, "period": "0y", "endDate": "2025-12-31", "growth": {}, "earningsEstimate": {"avg": {}, "low": {}, "high": {}, "yearAgoEps": {}, "numberOfAnalysts": {}, "growth": {}, "earningsCurrency": null}, "revenueEstimate": {"avg": {"raw": 23100000, "fmt": "23.1M", "longFmt": "23,100,000"}, "low": {"raw": 17500000, "fmt": "17.5M", "longFmt": "17,500,000"}, "high": {"raw": 30000000, "fmt": "30M", "longFmt": "30,000,000"}, "numberOfAnalysts": {"raw": 3, "fmt": "3", "longFmt": "3"}, "yearAgoRevenue": {"raw": 0, "fmt": null, "longFmt": "0"}, "growth": {"raw": 0.0, "fmt": "0.00%"}, "revenueCurrency": "USD"}, "epsTrend": {"current": {}, "7daysAgo": {}, "30daysAgo": {}, "60daysAgo": {}, "90daysAgo": {}, "epsTrendCurrency": null}, "epsRevisions": {"upLast7days": {}, "upLast30days": {}, "downLast30days": {}, "downLast7Days": {}, "downLast90days": {}, "epsRevisionsCurrency": null}}, {"maxAge": 1, "period": "+1y", "endDate": "2026-12-31", "growth": {}, "earningsEstimate": {"avg": {}, "low": {}, "high": {}, "yearAgoEps": {}, "numberOfAnalysts": {}, "growth": {}, "earningsCurrency": null}, "revenueEstimate": {"avg": {"raw": 129093250, "fmt": "129.09M", "longFmt": "129,093,250"}, "low": {"raw": 42573000, "fmt": "42.57M", "longFmt": "42,573,000"}, "high": {"raw": 241400000, "fmt": "241.4M", "longFmt": "241,400,000"}, "numberOfAnalysts": {"raw": 4, "fmt": "4", "longFmt": "4"}, "yearAgoRevenue": {"raw": 23100000, "fmt": "23.1M", "longFmt": "23,100,000"}, "growth": {"raw": 4.5885, "fmt": "458.85%"}, "revenueCurrency": "USD"}, "epsTrend": {"current": {}, "7daysAgo": {}, "30daysAgo": {}, "60daysAgo": {}, "90daysAgo": {}, "epsTrendCurrency": null}, "epsRevisions": {"upLast7days": {}, "upLast30days": {}, "downLast30days": {}, "downLast7Days": {}, "downLast90days": {}, "epsRevisionsCurrency": null}}], "defaultMethodology": "nongaap", "maxAge": 1}, "earningsHistory": {"history": [], "defaultMethodology": "nongaap", "maxAge": 86400}, "financialData": {"maxAge": 86400, "currentPrice": {"raw": 0.12, "fmt": "0.12"}, "targetHighPrice": {}, "targetLowPrice": {}, "targetMeanPrice": {}, "targetMedianPrice": {}, "recommendationMean": {}, "recommendationKey": "none", "numberOfAnalystOpinions": {}, "totalCash": {"raw": 2910000, "fmt": "2.91M", "longFmt": "2,910,000"}, "totalCashPerShare": {"raw": 0.148, "fmt": "0.15"}, "ebitda": {"raw": -14127500, "fmt": "-14.13M", "longFmt": "-14,127,500"}, "totalDebt": {"raw": 9854000, "fmt": "9.85M", "longFmt": "9,854,000"}, "quickRatio": {"raw": 0.072, "fmt": "0.07"}, "currentRatio": {"raw": 0.113, "fmt": "0.11"}, "totalRevenue": {}, "debtToEquity": {}, "revenuePerShare": {}, "returnOnAssets": {"raw": -1.74879, "fmt": "-174.88%"}, "returnOnEquity": {}, "grossProfits": {}, "freeCashflow": {"raw": 8726875, "fmt": "8.73M", "longFmt": "8,726,875"}, "operatingCashflow": {"raw": -11912000, "fmt": "-11.91M", "longFmt": "-11,912,000"}, "earningsGrowth": {}, "revenueGrowth": {}, "grossMargins": {"raw": 0.0, "fmt": "0.00%"}, "ebitdaMargins": {"raw": 0.0, "fmt": "0.00%"}, "operatingMargins": {"raw": 0.0, "fmt": "0.00%"}, "profitMargins": {"raw": 0.0, "fmt": "0.00%"}, "financialCurrency": "USD"}}